Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 T1370-p
Regulatory protein:
PRP4 S1166-p , T1381-p , S1383-p
Treatment:
angiotensin_2 S1182-p , S1257-p
anti-CD3 S1176-p
AZD1152 S1182-p , S1204-p
BI2536 S1176-p , S1177-p , S1182-p , S1319-p , S1358-p
BI_4834 S1162-p , S1165-p , T1301-p , S1319-p
EGF S1182-p
hesperadin S1162-p , S1165-p , S1176-p , S1177-p , S1182-p , S1319-p , S1416-p , S1417-p
ischemia T1121-p , S1176-p , S1182-p , S1257-p
lapatinib S1257-p
metastatic potential S1358-p
MG132 S1162-p , S1165-p , S1176-p , S1177-p , S1182-p , S1319-p , S1416-p , S1417-p
MG132_withdrawal S283-p , S1358-p
MLN8054 T518-p , T533-p , S1191-p , S1319-p
nocodazole T1121-p , S1162-p , S1165-p , S1166-p , S1176-p , S1177-p , S1182-p , S1283-p , T1301-p , S1319-p , S1358-p , T1370-p , S1416-p , S1417-p
rapamycin S1283-p
SB202190 S1182-p
selumetinib S1182-p , S1257-p
SII_angiotensin_2 S1257-p
vemurafenib S1182-p , S1257-p
ZM447439 S1182-p , S1204-p